01 Almirall at a glance:
2024, a year of visionary progress
KEY DATA & FIGURES OF 2024
€192.6 MM
EBITDA
€985.7 MM
NET SALES
+10.2% YoY
NET SALES GROWTH
NET SALES IN DERMATOLOGY
€548.1 MM
56% of total sales
+17.8% YoY
growth
NET SALES IN DERMATOLOGY BY GEOGRAPHY
EUROPE
88%
US
10%
RoW
2%
COLLABORATION & INNOVATION
12.6%
INVESTMENT OF NET SALES IN R&D
13
CURRENT PIPELINE PROJECTS
22
CURRENT R&D PARTNERSHIPS
ALMIRALL’S GLOBAL PRESENCE
total employees
2,026
country presence
+100
countries with direct presence
19
Patients
at the core
As part of our ongoing commitment to improve the lives of people with skin conditions, we continue to prioritize innovation and patient access, from our efforts in patient-centred programmes to development and research.
640,000
Patients treated with our key dermatology products
145
NUMBERS OF PRODUCTS
55
DERMATOLOGY PRODUCTS
Major Milestones in 2024
A year of groundbreaking achievements
Celebrating 80 years of history and innovation.
80 YEARS
of science, research, and innovation
OUR LONG-TERM STRATEGY
Our ambition is built on 4 pillars
Partnering with dermatologists
Transforming patients’ lives
Growing and innovating business
Making a mark in sustainability and social impact
Our business strategy builds on our unique company heritage, structure, and our focus on medical dermatology and innovation. As we have entered an era of sustained growth and profitability, we will continue to build our business based on our strategy phases.
